Vaccine to prevent Yellow Fever and Malaria

Project 134

Problem to be solved

• Disease of worldwide range
• Severe health problems
• Absence of available commercial vaccines

Proposed innovation

Bivalent recombinant vaccine to prevent yellow fever and malaria

Differential

• Use of attenuated yellow fever virus for the vaccine
• Vaccine known for its efficient human immunization
• Efficient expression of Plasmodium antigen
• Validated vaccinal platform
• Use of platform for other pathogens

Stage of development
Prototype

Intellectual property status
GB2372991 granted with corresponding applications filed in Brazil, the U.S., Europe, Australia, Canada, Cuba, ARIPO, Thailand and granted in South Africa, Colombia and OAPI
BRPI0504945-8 corresponding applications filed in Europe and the U.S.

What we want
Partnership

Coordinator
Myrna Cristina Bonaldo / IOC

Contact
Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br